Biropepimut-S
Biropepimut-S Uses, Dosage, Side Effects, Food Interaction and all others data.
Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity).
| Trade Name | Biropepimut-S |
| Generic | Biropepimut-S |
| Biropepimut-S Other Names | Biropepimut-S |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Biropepimut-S
